Silence Therapeutics (SLN) Earnings Date, Estimates & Call Transcripts → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free SLN Stock Alerts $22.00 -1.22 (-5.25%) (As of 05/23/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 21EstimatedActual EPS (May. 16) -$0.05 Beat By $0.18 Consensus EPS (May. 16) -$0.23 Get Silence Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for SLN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSLN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SLN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” Silence Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.46)($0.46)($0.46)Q2 20241($0.53)($0.53)($0.53)Q3 20241($0.53)($0.53)($0.53)Q4 20241($0.65)($0.65)($0.65)FY 20244($2.17)($2.17)($2.17)Q1 20251($0.65)($0.65)($0.65)Q2 20251($0.69)($0.69)($0.69)SLN Earnings Date and InformationSilence Therapeutics last posted its quarterly earnings data on May 16th, 2024. The reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.18. The firm had revenue of $15.73 million for the quarter, compared to the consensus estimate of $4.53 million. Silence Therapeutics has generated ($1.16) earnings per share over the last year (($1.16) diluted earnings per share). Earnings for Silence Therapeutics are expected to decrease in the coming year, from ($1.33) to ($1.36) per share. Silence Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 21st, 2024 based off prior year's report dates.Read More Silence Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/21/2024(Estimated)------- 5/16/2024Q1 2024($0.23)($0.05)+$0.18($0.05)$4.53 million$15.73 million3/13/2024Q4 2023($0.25)($0.47)($0.22)($0.47)$11.46 million$2.61 million11/14/2023Q3 2023($0.56)($0.28)+$0.28($0.28)$3.73 million$3.54 million8/16/2023Q2 2023($0.59)($0.36)+$0.23($0.36)$1.94 million$11.40 million5/16/2023Q1 2023($0.51)($0.35)+$0.16($0.35)$4.08 million$13.82 million3/15/2023Q4 2022$0.45($0.46)($0.91)($0.46)$36.30 million$5.59 million Get the Latest News and Ratings for SLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/10/2022Q3 2022($0.60)($0.25)+$0.35($0.25)-$3.97 million8/11/2022Q2 2022($0.60)($0.50)+$0.10($0.50)-$4.58 million5/16/2022Q1 2022($0.62)($0.35)+$0.27($0.35)-$7.68 million3/17/2022Q4 2021($0.62)($0.42)+$0.20($0.42)$2.74 million$4.60 million11/16/2021Q3 2021-($0.46)($0.46)($0.46)-$4.35 million Silence Therapeutics Earnings - Frequently Asked Questions When is Silence Therapeutics's earnings date? Silence Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 21st, 2024 based off last year's report dates. Learn more on SLN's earnings history. Did Silence Therapeutics beat their earnings estimates last quarter? In the previous quarter, Silence Therapeutics (NASDAQ:SLN) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.18. Learn more on analysts' earnings estimate vs. SLN's actual earnings. How much revenue does Silence Therapeutics generate each year? Silence Therapeutics (NASDAQ:SLN) has a recorded annual revenue of $31.55 million. How much profit does Silence Therapeutics generate each year? Silence Therapeutics (NASDAQ:SLN) has a recorded net income of -$53.82 million. SLN has generated -$1.16 earnings per share over the last four quarters. What is Silence Therapeutics's EPS forecast for next year? Silence Therapeutics's earnings are expected to decrease from ($1.33) per share to ($1.36) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ALX Oncology Earnings Date Sage Therapeutics Earnings Date CureVac Earnings Date Nuvation Bio Earnings Date Phibro Animal Health Earnings Date Lyell Immunopharma Earnings Date Praxis Precision Medicines Earnings Date Disc Medicine Earnings Date Pharvaris Earnings Date AnaptysBio Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: PDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets Uncertainty This page (NASDAQ:SLN) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis could mean the end of the U.S dollar…Colonial MetalsThis military-backed stock “owns” AI marketPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.